|
| |
pepgen corp Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio - Pepgen Corporation
Pepgen Corporation - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/28011-Pepgen+Corpor...
|
BioSpace - Pepgen Corporation News, Search Jobs, Events
Pepgen Corporation Raises $7.5 Million In Private Financing To Complete Phase II Clinical Study In Multiple Sclerosis 10/19/2005 5:11:19 PM More. ...
http://www.biospace.com/company_profile.aspx?CompanyId=18000...
|
BioPortfolio - pepgen tauferon
BioPortfolio - tauferon pepgen corp Pepgen Corporation, founded in 1992 by Dr. CP Liu, ... View the current Pepgen Corporation Page on BioPortfolio.com . ...
http://www.bioportfolio.com/search/pepgen_tauferon.html...
|
NIH Research Portfolio Online Reporting Tool (RePORT)
Detail for: PEPGEN CORPORATION. Select Year: 2005 | Historic Data. Dollars Awarded by Funding Mechanism. Funding Mechanism, Dollar Amount, Number Awarded
...
http://report.nih.gov/award/trends/FindOrg_Detail.cfm?OrgID=...
|
BioPortfolio - Pepgen Corporation
Pepgen Corporation - BioPortfolio. ... BioPortfolio ISK Biotech Corporation pepgen corp Pepgen Corporation 2301 30th ... Pepgen Corporation and 2008 ...
http://www.bioportfolio.com/search/Pepgen_Corporation.html...
|
PEPGEN CORPORATION All NIH Grants for FY 2005
PEPGEN CORPORATION. All NIH Grants for FY 2005. ... | PEPGEN CORPORATION | . R43AI055227-02 | ...
http://report.nih.gov/award/trends/InstInfoExcel.cfm?OrgID=3...
BioPortfolio - Pepgen Corporation patents
Pepgen Corporation patents - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/28011-Pepgen+Corpor...
|
{1} Raises $7.5 Million In Private Financing To Complete Phase II ...
3 /PRNewswire/ -- Pepgen Corporation, a biopharmaceutical company engaged in the development of novel autoimmune, inflammatory, and viral therapies ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1698312...
|
Licensing Highlights Saloni Shah , Danny Chan & Steven Tear
Pepgen Corp to develop further a process to produce. Neoferon, an interferon α2b analog, for which Pepgen plans. to initiate clinical trials in cancer and ...
http://www.biomedcentral.com/content/pdf/cd-625090.pdf...
|
UW-Eau Claire University Bulletin
Chih-Ping Liu ’74, founder and president of Pepgen Corp., Alameda, Calif. Nancy McKinley ’74, chief executive officer and editor in chief of Thinking ...
http://www.uwec.edu/Newsbureau/bulletin/2003-04/09-29-03/ubi...
| 
|
| |
Nothing in this website should be used in
place of personal medical advice from your own qualified medical
practitioner.
|
All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited. |
|
|
